Login to Your Account

Pharma: Other News To Note

Tuesday, April 3, 2012
• Ampio Pharmaceuticals Inc., of Greenwood Village, Colo., reported that it reached a manufacturing and quality control agreement with Australia's Therapeutic Goods Administration for Zertane (low-dose tramadol). It plans to file the draft registration submission in June for the repurposed medication designed to treat premature ejaculation. No additional clinical trials are expected to be required.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription